Human recombinant erythropoietin in asphyxia neonatorum: Pilot trial

Pediatrics

Volumn 125, Issue 5, 2010, Pages

  Elmahdy, Heba ^a   El Mashad, Abdel Rahman ^a   El Bahrawy, Hoda ^a   El Gohary, Tareq ^a   El Barbary, Ali ^a   Aly, Hany ^b  

^a TANTA UNIVERSITY   (Egypt)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Electroencephalography; Erythropoietin; Hypoxic ischemic encephalopathy; Infants; MRI; Nitric oxide

Indexed keywords

NITRIC OXIDE; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD LEVEL; BRAIN HYPOXIA; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DENVER DEVELOPMENTAL SCREENING TEST II; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEASIBILITY STUDY; FEMALE; HUMAN; INCIDENCE; MALE; NEUROANATOMY; NEUROLOGIC EXAMINATION; NEUROLOGICAL COMPLICATION; NEUROPHYSIOLOGY; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SEIZURE;

ASPHYXIA NEONATORUM; BRAIN; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT; INFANT, NEWBORN; INJECTIONS, SUBCUTANEOUS; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; NITRIC OXIDE; PROSPECTIVE STUDIES;

EID: 77951806448     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-2268     Document Type: Article

References (42)

1. Volpe J. Neurology of the Newborn. 5th ed. Philadelphia, PA: Saunders; 2008: 245-372
2. Vannucci RC. Hypoxic-ischemic encephalopathy. Am J Perinatol. 2000;17(3):113-120
3. Vannucci RC, Perlman JM. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics. 1997;100(6): 1004-1014
4. Rehncrona S, Westerberg E, Akesson B, Siesjö BK. Brain cortical fatty acids and phospholipids during and following complete and severe incomplete ischemia. J Neurochem. 1982;38(1):84-93 (Pubitemid 12189198)
5. Holecek V, Racek J, Trefil L, Rokyta R. Free radicals and antioxidants in cerebrospinal fluid in central nervous system diseases. Cesk Fysiol. 2002;51(3):129-132
6. Hamada Y, Hayakawa T, Hattori H, Mikawa H. Inhibitor of nitric oxide synthesis reduces hypoxic/ischemic brain damage in the neonatal rat. Pediatr Res. 1994;35(1): 10-14 (Pubitemid 24004627)
7. Sasaki R. Pleiotropic functions of erythropoietin. Intern Med. 2003;42(2):142-149
8. Sirén AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A. 2001;98(7): 4044-4049 (Pubitemid 32249895)
9. Deulofeut R, Sola A. Injury to the developing brain in term and preterm infants: mechanisms of injury and potential for prevention and repair. J Arab Neonatol Forum. 2005; 2(1):34-47
10. Sola A, Wen TC, Hamrick SE, Ferriero DM. Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res. 2005;57(5): 110R-117R (Pubitemid 40593255)
11. Sakanaka M, Wen TC, Matsuda S, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A. 1998;95(8): 4635-4640 (Pubitemid 28207965)
12. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76(1): 105-116 (Pubitemid 26407940)
13. Aydin A, Genç K, Akhisaroglu M, Yorukoglu K, Gokmen N, Gonullu E. Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain Dev. 2003;25(7):494-498 (Pubitemid 37485656)
14. Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A. 2000;97(19): 10526-10531
15. Dame C, Juul SE, Christensen RD. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate. 2001; 79(3- 4):228-235 (Pubitemid 32247092)
16. Hasselblatt M, Ehrenreich H, Sirén AL. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol. 2006;18(2): 132-138 (Pubitemid 44510112)
17. Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics. 2009;124(2). Available at: www.pediatrics.org/cgi/content/full/124/ 2/e218
18. American Academy of Pediatrics; American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 5th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2002:196-197
19. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard score, expanded to include extremely premature infants. J Pediatr. 1991;119(3): 417-423
20. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress: a clinical electroencephalographic study. Arch Neurol. 1976;33(10):696-705
21. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5(1):62-71 (Pubitemid 34146173)
22. Curzie DL. Manual of Methods for Recording and Analyzing Sleep-Wakefulness States in Preterm and Full-Term Infants. Paris, France: Editions INSERM; 2008:1-130
23. Biagioni E, Bartalena L, Boldrini A, Pieri R, Cioni G. Constantly discontinuous EEG patterns in full-term neonates with hypoxicischemic encephalopathy. Clin Neurophysiol. 1999;110(9):1510-1515 (Pubitemid 29410421)
24. Biagioni E, Mercuri E, Rutherford M, et al. Combined use of electroencephalogram and magnetic resonance imaging in full term neonates with acute encephalopathy. Pediatrics. 2001;107(3):461-468 (Pubitemid 32183177)
25. Biagioni E, Boldrini A, Bottone U, Pieri R, Cioni G. Prognostic value of abnormal EEG transients in preterm and full-term neonates. Electroencephalogr Clin Neurophysiol. 1996;99(1):1-9 (Pubitemid 26241831)
26. Barkovich AJ, Hajnal BL, Vigneron D, et al. Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol. 1998; 19(1):143-149 (Pubitemid 30430598)
27. Miller SP, Ramaswamy V, Michelson D, et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr. 2005;146(4): 453-460 (Pubitemid 40469706)
28. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick B. The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics. 1992;89(1):91-97
29. Shi Y, Pan F, Li H, Pan J, Qin S, Shen C. Role of carbon monoxide and nitric oxide in newborn infants with postasphyxial hypoxicischemic encephalopathy. Pediatrics. 2000; 106(6):1447-1451
30. Thorat VN , Suryakar AN, Sardeshmukh AS, Sarawade SS. Oxidants and antioxidants in hypoxic ischaemic encephalopathy. Indian J Clin Biochem. 2004;19(2):32-35
31. Genc K, Genc S, Baskin H, Semin I. Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes. Physiol Res. 2006;55(1):33-38 (Pubitemid 43276809)
32. Sasaki R, Masuda S, Nagao M. Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem. 2000;64(9):1775-1793
33. Calapai G, Marciano MC, Corica F, et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol. 2000;401(3): 349-356 (Pubitemid 30608719)
34. Yang J, Huang YG, Yu X, Sun H, Li Y, Deng Y. Erythropoietin preconditioning suppresses neuronal death following status epilepticus in rats. Acta Neurobiol Exp (Wars). 2007; 67(2):141-148 (Pubitemid 47066466)
35. Mikati MA, El Hokayem JA, El Sabban ME. Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10. Epilepsia. 2007;48(1):175-181
36. Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8(8):495-505 (Pubitemid 36337492)
37. Chang YS, Mu D, Wendland M, et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res. 2005;58(1):106-111 (Pubitemid 40967438)
38. Juul SE. Erythropoietin as a neonatal neuroprotectant: basic and clinical studies. Haematol Rep. 2006;2(10):98-102
39. Ehrenreich H, Fischer B, Norra C, et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain. 2007;130(10):2577-2588 (Pubitemid 47511714)
40. Ehrenreich H, Hinze-Selch D, Stawicki S, et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry. 2007;12(2):206-220
41. Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics. 2008; 122(2):383-391
42. Juul SE, Ledbetter DJ, Joyce AE, et al. Erythropoietin acts as a trophic factor in neonatal rat intestine. Gut. 2001;49(2): 182-189